Haemophilia is quite a rare disease, with approximately one in 10,000 people born with haemophilia, and hereditary (i.e. passed on through the parents’ genes)

. It causes a failure of the blood to coagulate. As a result, people with haemophilia do not bleed faster than normal, but bleed for longer.

World Haemophilia Day is on Friday 17 April. On this occasion, the institutes and associations, particularly the World Federation of Haemophilia, work to sensitise and inform the general public and caregivers about hereditary coagulation disorders.

Throughout the year, research is conducted by the Inserm teams to improve replacement therapies.

Bleeding disorders (including haemophilia) are the main concern of the team led by Cécile Denis in Inserm Unit 1176, “Haemostasis–Inflammation–Thrombosis.” The researchers’ work is focused on the development of innovative therapies, such as gene therapy, which could be used to treat this disorder.